tradingkey.logo

WGRX

WGRX
View Detailed Chart
0.312USD
-0.007-2.10%
Close 02/06, 16:00ETQuotes delayed by 15 min
27.89MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D

Today

-2.10%

5 Days

-13.05%

1 Month

-25.76%

6 Months

-61.51%

Year to Date

-21.95%

1 Year

0.00%

View Detailed Chart

TradingKey Stock Score of WGRX

Currency: USD Updated: 2026-02-06

Key Insights

Wellgistics Health Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is good.Its valuation is considered fairly valued, ranking 148 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

WGRX's Score

Industry at a Glance

Industry Ranking
148 / 205
Overall Ranking
491 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

WGRX Highlights

StrengthsRisks
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
Growing
The company is in a growing phase, with the latest annual income totaling USD 18.13M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 18.13M.
Overvalued
The company’s latest PE is -0.25, at a high 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 851.12K shares of this stock.

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

WGRX News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

WGRX Info

Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
Ticker SymbolWGRX
CompanyWellgistics Health Inc
CEOMr. Brian Norton
Websitehttps://wellgisticshealth.com/
KeyAI